MMP9 and cystic fibrosis: Thus, routine markers reliably indicating the occurrence of pulmonary exacerbations in CF are of clinical need, and our results indicate that MMP-8, MMP-9, and YKL-40 might indeed be utilized as novel serum markers facilitating the diagnosis of PEx.